Neoleukin Therapeutics Presents Preclinical Combination Data for NL-201 at Society for Immunotherapy of Cancer’s 35th Anniversary Annual Meeting (SITC 2020)

NEXT STORY
Beroni Group Launches a New Probiotics Health Product in China
PREV STORY
Genmab to Present at Jefferies Virtual London Healthcare Conference
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Rheumatology Therapeutics Market Will Reach USD 50.9 Billion by 2022: Zion Market Research

New York, NY, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published ...

author_avatar
NASDAQ Market News

Healthcare Consumers Increasingly Making Payments Online, New athenahealth Research Shows

author_avatar
NASDAQ Market News

Intellia and Regeneron Announce Landmark Clinical Data Showing Deep Reduction in Disease-Causing Protein After Single Infusion of NTLA-2001, an Investigational CRISPR Therapy for Transthyretin (ATTR) Amyloidosis

author_avatar
NASDAQ Market News